A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer

Clinical trial NCT03602859 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03602859
Sponsor: Tesaro, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Neoplasms Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma

Start date: 2018-10-11
Primary completion: 2024-10-31
Enrollment: 1400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.